Literature DB >> 6235443

Effect of 5-fluoro-2'-deoxyuridine and hydroxyurea on the phytohemagglutinin-induced increase of thymidine kinase, replicative DNA polymerase, deoxycytidylate deaminase and CDP reductase activities in human lymphocytes.

G Tyrsted.   

Abstract

The inhibitors of DNA synthesis, 5-fluoro-2'-deoxyuridine and hydroxyurea, caused an inhibition of thymidine kinase, replicative DNA polymerase and CDP reductase activities in stimulated lymphocytes when they were exposed to the inhibitors during the early transformation period (0-17 hr). However, the enzyme activities were unaffected when the inhibitors were added to cells stimulated for more than 17 hr. As opposed to these enzymes the deoxycytidylate deaminase activity was unaffected by the inhibitors during the entire transformation period (0-28 hr). This indicates a close regulatory mechanism in lymphocytes between DNA synthesis and induction of enzymes involved in DNA replication. The inhibitory mechanism exerted by the inhibitors is for the moment unknown. It might be independent of the well-known inhibition of the target enzymes, thymidylate synthetase and ribonucleoside diphosphate reductase, since there was no immediate apparent correlation in time between depletion of the pool sizes and the inhibition of the enzyme activities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235443     DOI: 10.1007/bf00223307

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  END-PRODUCT INHIBITION OF THYMIDINE KINASE ACTIVITY IN NORMAL AND LEUKEMIC HUMAN LEUKOCYTES.

Authors:  E BRESNICK; R J KARJALA
Journal:  Cancer Res       Date:  1964-06       Impact factor: 12.701

2.  Changes in the deoxyribonucleoside triphosphate pools of mouse 5178Y lymphoma cells following exposure to methotrexate or 5-fluorouracil.

Authors:  M H Tattersall; K R Harrap
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

3.  Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2'-deoxyuridylate.

Authors:  R J Langenbach; P V Danenberg; C Heidelberger
Journal:  Biochem Biophys Res Commun       Date:  1972-09-26       Impact factor: 3.575

4.  DNA polymerase activity in phytohemagglutinin-stimulated and non-stimulated human lymphocytes.

Authors:  G Tyrsted; B Munch-Petersen; L Cloos
Journal:  Exp Cell Res       Date:  1973-03-15       Impact factor: 3.905

5.  DNA polymerase activity of cultured normal and leukemic lymphocytes. Response to phytohemagglutinin.

Authors:  Y Rabinowitz; I S McCluskey; P Wong; B A Wilhite
Journal:  Exp Cell Res       Date:  1969-10       Impact factor: 3.905

6.  A rapid assay for CDP reductase activity in mammalian cell extracts.

Authors:  J R Steeper; C D Steuart
Journal:  Anal Biochem       Date:  1970-03       Impact factor: 3.365

7.  Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate.

Authors:  D V Santi; C S McHenry; H Sommer
Journal:  Biochemistry       Date:  1974-01-29       Impact factor: 3.162

8.  Effect of arabinosyl cytosine on the level of DNA polymerase and thymidine kinase activity in PHA-stimulated human tonsillar lymphocytes.

Authors:  M Staub; M Sasvári-Székely; T Spasokukockaja; F Antoni
Journal:  Mol Cell Biochem       Date:  1982-01-16       Impact factor: 3.396

9.  HYDROXYUREA: INHIBITORY EFFECT ON DNA METABOLISM.

Authors:  C W YOUNG; S HODAS
Journal:  Science       Date:  1964-11-27       Impact factor: 47.728

10.  Thymidylate synthetase and dihydrofolic acid reductase in the stimulated human lymphocyte.

Authors:  F I Haurani; C G Kardinal; W A Biermann
Journal:  J Cell Physiol       Date:  1978-04       Impact factor: 6.384

View more
  2 in total

1.  Deoxycytidylate deaminase activity in non-stimulated and phytohemagglutinin-stimulated human lymphocytes, and in leukemic cells.

Authors:  G Tyrsted; P C Chao; B Munch-Petersen
Journal:  Mol Cell Biochem       Date:  1987-07       Impact factor: 3.396

2.  Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.

Authors:  J M Schröder; M Bertram; R Schnabel; U Pfaff
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.